Status:
COMPLETED
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
Eligibility Criteria
Inclusion
- Diabetes mellitus Type 2
Exclusion
- Severe Asthma, severe COPD
- Smoking
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00367445
Start Date
September 1 2006
End Date
February 1 2007
Last Update
January 29 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chula Vista, California, United States